ctrl K

Price Alert

Turning Point Therapeutic... (TPTX)

NASDAQ: TPTX · Real-Time Price · USD

75.49

0.09 (0.12%)

At close: Aug 15, 2022, 10:00 PM

Turning Point Therapeutics Revenue Breakdown

Period Ending	Dec 31, 2020
Clinical Supply Revenue	700K
Clinical Supply Revenue Growth	n/a

Operating Expense Breakdown

Period Ending	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018
Selling, General, and Administrative Revenue	37.7M	20.31M	20.46M	18.22M	17.17M	19.99M	13.66M	11.33M	8.58M	39.86M	5.92M	5.5M	4.74M	3.61M	2.26M	1M	803K	516K
Selling, General, and Administrative Revenue Growth	+85.56%	-0.73%	+12.29%	+6.13%	-14.11%	+46.30%	+20.64%	+32.04%	-78.48%	+572.81%	+7.71%	+15.96%	+31.28%	+59.94%	+125.90%	+24.53%	+55.62%	n/a
Research and Development Revenue	86.79M	55.05M	58.18M	48.89M	44.65M	41.26M	34.27M	32.21M	24.15M	22.77M	17.14M	16.64M	13.71M	10.45M	7.22M	5.13M	4.37M	4.34M
Research and Development Revenue Growth	+57.65%	-5.37%	+19.00%	+9.49%	+8.21%	+20.39%	+6.40%	+33.37%	+6.08%	+32.83%	+3.01%	+21.36%	+31.19%	+44.73%	+40.79%	+17.40%	+0.58%	n/a